Methods of making, using and pharmaceutical formulations comprising 7α, 11β-dimethyl-17β-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
First Claim
Patent Images
1. A method for providing hormonal therapy to a patient comprising the oral administration of an androgen selected from the group consisting of 7α
- ,11β
-dimethyl-17β
hydroxyestra-4,14-dien-3-one, 17-ester of 7α
,11β
-dimethyl-17β
-hydroxyestra-4,14-dien-3-one, or mixtures thereof in an amount effective to provide hormonal therapy to a patient in need thereof, wherein the hormonal therapy is selected from the group consisting of hormone replacement therapy in males and females, male contraception, treatment of breast cancer, promotion and maintenance of muscle mass in a patient, treatment of osteoporosis, treatment of anemia, treatment for anabolic support, and hypergonadotropic conditions.
2 Assignments
0 Petitions
Accused Products
Abstract
Methods of using 7α,11β-dimethyl-17β-hydroxyestra-4,14-dien-3-one (III)
and 17 esters thereof for various hormonal therapies, oral and parenteral dosage forms comprising these actives, and processes for their preparation.
-
Citations
96 Claims
-
1. A method for providing hormonal therapy to a patient comprising the oral administration of an androgen selected from the group consisting of 7α
- ,11β
-dimethyl-17β
hydroxyestra-4,14-dien-3-one, 17-ester of 7α
,11β
-dimethyl-17β
-hydroxyestra-4,14-dien-3-one, or mixtures thereof in an amount effective to provide hormonal therapy to a patient in need thereof, wherein the hormonal therapy is selected from the group consisting of hormone replacement therapy in males and females, male contraception, treatment of breast cancer, promotion and maintenance of muscle mass in a patient, treatment of osteoporosis, treatment of anemia, treatment for anabolic support, and hypergonadotropic conditions. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50)
- ,11β
-
51. A method for providing hormonal therapy to a patient comprising administering parenterally to the patient an androgen selected from the group consisting of 7α
- ,11β
-dimethyl-17β
-hydroxyestra-4,14-dien-3-one, a 17-ester of 7α
,11β
-dimethyl-17β
-hydroxyestra-4,14-dien-3-one, and mixtures thereof in an amount effective to provide hormonal therapy to the patient, wherein the hormonal therapy is selected from the group consisting of hormone replacement therapy in males and females, male contraception, treatment of breast cancer, promotion and maintenance of muscle mass in a patient, treatment of osteoporosis, treatment of anemia, treatment for anabolic support, and hypergonadotropic conditions. - View Dependent Claims (52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96)
- ,11β
Specification